Find Sacubitril-Valsartan manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

Australia

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sacubitril valsartan sodium hydrate, Sacubitril mixture with valsartan, Wb8ft61183, Lcz 696, Sacubitril valsartan sodium hydrate (jan), Sacubitril valsartan sodium hydrate [jan]
Molecular Formula
C96H120N12Na6O21
Molecular Weight
1916.0  g/mol
InChI Key
ZASXKEGREHRXDL-CAWNUZPDSA-H
FDA UNII
WB8FT61183

Sacubitril-Valsartan
Sacubitril/Valsartan is a combination of sacubitril and valsartan with natriuretic and anti-hypertensive properties. Upon administration, sacubitril is metabolized by esterases to its active metabolite, LBQ657 (sacubitrilat), which inhibits neprilysin, a neutral endopeptidase that cleaves natriuretic peptides such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and c-type natriuretic peptide (CNP), as well as certain vasoconstricting peptides including as angiotensin I and II, and endothelin-1. Inhibition of neprilysin leads to increased concentrations of endogenous natriuretic peptides, which function to activate downstream receptors that promote vasodilation, natriuresis and diuresis, while simultaneously increasing the concentration of vasoconstricting peptides such as angiotensin II. Co-administration with valsartan, an angiotensin II receptor blocker, prevents the vasoconstrictive effects of neprilysin inhibition and promotes a decrease in vascular resistance and blood pressure.
1 2D Structure

Sacubitril-Valsartan

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
hexasodium;4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate;(2S)-3-methyl-2-[pentanoyl-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]amino]butanoate;pentahydrate
2.1.2 InChI
InChI=1S/2C24H29N5O3.2C24H29NO5.6Na.5H2O/c2*1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23;2*1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19;;;;;;;;;;;/h2*6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H2,25,26,27,28,31,32);2*4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28);;;;;;;5*1H2/q;;;;6*+1;;;;;/p-6/t2*22-;2*17-,21+;;;;;;;;;;;/m0011.........../s1
2.1.3 InChI Key
ZASXKEGREHRXDL-CAWNUZPDSA-H
2.1.4 Canonical SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)C(C(C)C)C(=O)[O-].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)C(C(C)C)C(=O)[O-].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
2.1.5 Isomeric SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
2.2 Other Identifiers
2.2.1 UNII
WB8FT61183
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate

2. Lcz 696

3. Lcz-696

4. Lcz696

5. Sacubitril And Valsartan Drug Combination

6. Sacubitril And Valsartan Sodium Anhydrous Drug Combination

7. Sacubitril And Valsartan Sodium Hydrate Drug Combination

8. Sacubitril Valsartan Drug Combination

9. Sacubitril Valsartan Sodium Anhydrous

10. Sacubitril Valsartan Sodium Hydrate

11. Sacubitril-valsartan

12. Sacubitril-valsartan Sodium Anhydrous Drug Combination

13. Sacubitril-valsartan Sodium Hydrate Drug Combination

14. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate

2.3.2 Depositor-Supplied Synonyms

1. Sacubitril Valsartan Sodium Hydrate

2. Sacubitril Mixture With Valsartan

3. Wb8ft61183

4. Lcz 696

5. Sacubitril Valsartan Sodium Hydrate (jan)

6. Sacubitril Valsartan Sodium Hydrate [jan]

7. Entresto (tn)

8. Unii-wb8ft61183

9. Valsartan Mixture With Ahu-377

10. Ex-a2849

11. Mfcd29477717

12. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate

13. Ac-29037

14. Sucabitril Valsartan Sodium Hydrate

15. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate

16. D10226

17. Valsartan Ahu-377 Sodium Hemipentahydrate

18. Q27292546

19. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With .alpha.-ethyl (.alpha.r,.gamma.s)-.gamma.-((3-carboxy-1-oxopropyl)amino)-.alpha.-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)

20. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With Alpha-ethyl(alphar,gammas)-gamma-((3-carboxy-1-oxopropyl)amino)-alpha-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)

2.4 Create Date
2013-05-27
3 Chemical and Physical Properties
Molecular Weight 1916.0 g/mol
Molecular Formula C96H120N12Na6O21
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count29
Rotatable Bond Count40
Exact Mass1915.8110694 g/mol
Monoisotopic Mass1914.8077146 g/mol
Topological Polar Surface Area396 Ų
Heavy Atom Count135
Formal Charge0
Complexity1140
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count15
4 Drug and Medication Information
4.1 Drug Indication

Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Angiotensin Receptor Antagonists

Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. (See all compounds classified as Angiotensin Receptor Antagonists.)


5.2 ATC Code

C09DX04


EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Sacubitril/Valsartan IH

Date of Issue : 2022-07-28

Valid Till : 2025-11-30

Written Confirmation Number : WC-0390

Address of the Firm : Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District -532409, Andhr...

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

Sacubitril Valsartan Trisodium Salt Hemipentahydrate IH

Date of Issue : 2025-08-05

Valid Till : 2028-06-25

Written Confirmation Number : WC-0054

Address of the Firm : Block No. 82/B, ECP Road, At & Post Karakhadi, Tal - Padra, Dist. Baroda, Gujara...

AMI Lifesciences

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Sacubutril Valsartan Sodium on Colloidal SiliconDioxide IH

Date of Issue : 2025-09-03

Valid Till : 2028-09-02

Written Confirmation Number : WC-0362

Address of the Firm : Plot No:4, Hetero Infrastructure SEZ Ltd.,Narasapuram, Visakhapatnam-531081, And...

Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Sacubitril Valsartan Sodium Hydrate IH

Date of Issue : 2025-09-03

Valid Till : 2028-09-02

Written Confirmation Number : WC-0362

Address of the Firm : Plot No:4, Hetero Infrastructure SEZ Ltd.,Narasapuram, Visakhapatnam-531081, And...

Company Banner

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Valsartan Trisodium Hemipentahydrate IH

Date of Issue : 2025-08-22

Valid Till : 2028-08-21

Written Confirmation Number : WC-0082

Address of the Firm : Karakhadi, Plot No. 842-843, At - Karakhdi, Tal. - Padra, Dist -Vadodara, Gujara...

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Valsartan IH

Date of Issue : 2024-07-18

Valid Till : 2027-06-07

Written Confirmation Number : WC-0317

Address of the Firm : Plot No. 43 & 44, IDA Phase-ll, Pashamylaram, Pashamylaram(V), Patancheru (M), S...

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Valsartan Sodium Hydrate IH IH

Date of Issue : 2025-06-27

Valid Till : 2028-06-16

Written Confirmation Number : WC-0030

Address of the Firm : Unit-2 Annavaram (Post), Chippada Village,Bheemunipatnam Mandal, Visakhapatnam D...

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril / Valsartan IH

Date of Issue : 2025-10-16

Valid Till : 2028-07-21

Written Confirmation Number : WC-0044

Address of the Firm : Plot No. A-100, A-100/1, A-100/2 & D-1, M.I.D.C Ind. Area, Shendra, Aurangabad-4...

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Valsartan IH

Date of Issue : 2023-09-25

Valid Till : 2026-03-20

Written Confirmation Number : WC-0453

Address of the Firm : Plot NO.E-41,129&128/2, MIDCInd.Area,Tarapur,Boisar-401 506, Maharashtra, India

blank

10

Laurus Labs

India
PEGS Boston Summit
Not Confirmed
arrow

Laurus Labs

India
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Valsartan 3Na Complex IH

Date of Issue : 2025-09-24

Valid Till : 2028-09-23

Written Confirmation Number : WC-0213

Address of the Firm : Unit-I, Plot No.21, Jawaharlal Nehru Pharma City, Parawada Mandal, Anakapalli Di...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69037-0040

Start Marketing Date : 2015-07-07

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69037-0082

Start Marketing Date : 2015-07-07

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69037-0039

Start Marketing Date : 2015-07-07

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69037-0043

Start Marketing Date : 2015-07-07

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Company Banner

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 59651-335

Start Marketing Date : 2025-07-29

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (43kg/50kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL VALSARTAN

NDC Package Code : 52562-032

Start Marketing Date : 2024-12-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 66064-1026

Start Marketing Date : 2017-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL VALSARTAN

NDC Package Code : 33342-605

Start Marketing Date : 2025-09-03

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (4kg/4kg)

Marketing Category : BULK INGREDIENT

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69766-042

Start Marketing Date : 2017-12-15

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL VALSARTAN SODIUM HYDRATE

NDC Package Code : 69766-062

Start Marketing Date : 2018-12-31

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Accord Healthcare Bv

United Kingdom
PEGS Boston Summit
Not Confirmed
arrow

Accord Healthcare Bv

United Kingdom
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Sodium|Valsartan Disodium

Brand Name : Sacubitril/Valsartan Accord

Dosage Form : Film Coated Tablet

Dosage Strength : 24mg;26mg

Packaging :

Approval Date : 14-07-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Accord Healthcare Bv

United Kingdom
PEGS Boston Summit
Not Confirmed
arrow

Accord Healthcare Bv

United Kingdom
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Sodium|Valsartan Disodium

Brand Name : Sacubitril/Valsartan Accord

Dosage Form : Film Coated Tablet

Dosage Strength : 49mg;51mg

Packaging :

Approval Date : 14-07-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Accord Healthcare Bv

United Kingdom
PEGS Boston Summit
Not Confirmed
arrow

Accord Healthcare Bv

United Kingdom
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril Sodium|Valsartan Disodium

Brand Name : Sacubitril/Valsartan Accord

Dosage Form : Film Coated Tablet

Dosage Strength : 97mg;103mg

Packaging :

Approval Date : 14-07-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril|Valsartan

Brand Name : Entresto

Dosage Form : Film Coated Tablet

Dosage Strength : 48.6mg;51.4mg

Packaging :

Approval Date : 17/09/2015

Application Number : 65673

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sakubitril-Valsartannatriumhydrat

Brand Name : Neparvis

Dosage Form : Film Coated Tablet

Dosage Strength : 24mg;26mg

Packaging :

Approval Date : 26-05-2016

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sakubitril-Valsartannatriumhydrat

Brand Name : Entresto

Dosage Form : Capsule

Dosage Strength :

Packaging :

Approval Date : 26-05-2023

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril; Valsartan

Brand Name : Sacubitril/Valsartan Stada

Dosage Form : Film Coated Tablet

Dosage Strength : 24mg; 26mg

Packaging :

Approval Date : 11-11-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

08

TEVA GmbH

Israel
PEGS Boston Summit
Not Confirmed
arrow

TEVA GmbH

Israel
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril; Valsartan

Brand Name : Sacubitril/Valsartan Teva

Dosage Form : Film Coated Tablet

Dosage Strength : 97mg; 103mg

Packaging :

Approval Date : 22-07-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

09

axunio Pharma GmbH

Country
PEGS Boston Summit
Not Confirmed
arrow

axunio Pharma GmbH

Country
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril; Valsartan

Brand Name : Sacubitril/Valsartan Axunio

Dosage Form : Film Coated Tablet

Dosage Strength : 24mg; 26mg

Packaging :

Approval Date : 17-10-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

axunio Pharma GmbH

Country
PEGS Boston Summit
Not Confirmed
arrow

axunio Pharma GmbH

Country
arrow
PEGS Boston Summit
Not Confirmed

Sacubitril; Valsartan

Brand Name : Sacubitril/Valsartan Axunio

Dosage Form : Film Coated Tablet

Dosage Strength : 49mg; 51mg

Packaging :

Approval Date : 17-10-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX)

Brand Name : ENTRESTO

Dosage Form : TABLET

Dosage Strength : 24MG

Packaging : 30

Approval Date :

Application Number : 2446928

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX)

Brand Name : ENTRESTO

Dosage Form : TABLET

Dosage Strength : 49MG

Packaging : 60

Approval Date :

Application Number : 2446936

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX)

Brand Name : ENTRESTO

Dosage Form : TABLET

Dosage Strength : 97MG

Packaging : 60

Approval Date :

Application Number : 2446944

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

VALSARTAN (SACUBITRIL VALSARTAN SODIUM COMPLEX)

Brand Name : PMS-SACUBITRIL-VALSARTAN

Dosage Form : TABLET

Dosage Strength : 26MG

Packaging :

Approval Date :

Application Number : 2564432

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL (SACUBITRIL VALSARTAN SODIUM COMPLEX)

Brand Name : PMS-SACUBITRIL-VALSARTAN

Dosage Form : TABLET

Dosage Strength : 24MG

Packaging :

Approval Date :

Application Number : 2564432

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

VALSARTAN (SACUBITRIL VALSARTAN SODIUM COMPLEX)

Brand Name : PMS-SACUBITRIL-VALSARTAN

Dosage Form : TABLET

Dosage Strength : 51MG

Packaging :

Approval Date :

Application Number : 2564440

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL (SACUBITRIL VALSARTAN SODIUM COMPLEX)

Brand Name : PMS-SACUBITRIL-VALSARTAN

Dosage Form : TABLET

Dosage Strength : 49MG

Packaging :

Approval Date :

Application Number : 2564440

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

VALSARTAN (SACUBITRIL VALSARTAN SODIUM COMPLEX)

Brand Name : PMS-SACUBITRIL-VALSARTAN

Dosage Form : TABLET

Dosage Strength : 103MG

Packaging :

Approval Date :

Application Number : 2564459

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX)

Brand Name : SANDOZ SACUBITRIL-VALSARTAN

Dosage Form : TABLET

Dosage Strength : 24MG

Packaging :

Approval Date :

Application Number : 2549018

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX)

Brand Name : SANDOZ SACUBITRIL-VALSARTAN

Dosage Form : TABLET

Dosage Strength : 49MG

Packaging :

Approval Date :

Application Number : 2549026

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 936623-90-4 / Sacubitril-Valsartan API manufacturers, exporters & distributors?

Sacubitril-Valsartan manufacturers, exporters & distributors 1

72

PharmaCompass offers a list of Sacubitril-Valsartan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sacubitril-Valsartan manufacturer or Sacubitril-Valsartan supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sacubitril-Valsartan manufacturer or Sacubitril-Valsartan supplier.

API | Excipient name

Sacubitril-Valsartan

Synonyms

Sacubitril valsartan sodium hydrate, Sacubitril mixture with valsartan, Wb8ft61183, Lcz 696, Sacubitril valsartan sodium hydrate (jan), Sacubitril valsartan sodium hydrate [jan]

Cas Number

936623-90-4

Unique Ingredient Identifier (UNII)

WB8FT61183

About Sacubitril-Valsartan

Sacubitril/Valsartan is a combination of sacubitril and valsartan with natriuretic and anti-hypertensive properties. Upon administration, sacubitril is metabolized by esterases to its active metabolite, LBQ657 (sacubitrilat), which inhibits neprilysin, a neutral endopeptidase that cleaves natriuretic peptides such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and c-type natriuretic peptide (CNP), as well as certain vasoconstricting peptides including as angiotensin I and II, and endothelin-1. Inhibition of neprilysin leads to increased concentrations of endogenous natriuretic peptides, which function to activate downstream receptors that promote vasodilation, natriuresis and diuresis, while simultaneously increasing the concentration of vasoconstricting peptides such as angiotensin II. Co-administration with valsartan, an angiotensin II receptor blocker, prevents the vasoconstrictive effects of neprilysin inhibition and promotes a decrease in vascular resistance and blood pressure.

Sacubitril And Valsartan Manufacturers

A Sacubitril And Valsartan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sacubitril And Valsartan, including repackagers and relabelers. The FDA regulates Sacubitril And Valsartan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sacubitril And Valsartan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sacubitril And Valsartan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Sacubitril And Valsartan Suppliers

A Sacubitril And Valsartan supplier is an individual or a company that provides Sacubitril And Valsartan active pharmaceutical ingredient (API) or Sacubitril And Valsartan finished formulations upon request. The Sacubitril And Valsartan suppliers may include Sacubitril And Valsartan API manufacturers, exporters, distributors and traders.

click here to find a list of Sacubitril And Valsartan suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Sacubitril And Valsartan USDMF

A Sacubitril And Valsartan DMF (Drug Master File) is a document detailing the whole manufacturing process of Sacubitril And Valsartan active pharmaceutical ingredient (API) in detail. Different forms of Sacubitril And Valsartan DMFs exist exist since differing nations have different regulations, such as Sacubitril And Valsartan USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Sacubitril And Valsartan DMF submitted to regulatory agencies in the US is known as a USDMF. Sacubitril And Valsartan USDMF includes data on Sacubitril And Valsartan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sacubitril And Valsartan USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Sacubitril And Valsartan suppliers with USDMF on PharmaCompass.

Sacubitril And Valsartan KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Sacubitril And Valsartan Drug Master File in Korea (Sacubitril And Valsartan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sacubitril And Valsartan. The MFDS reviews the Sacubitril And Valsartan KDMF as part of the drug registration process and uses the information provided in the Sacubitril And Valsartan KDMF to evaluate the safety and efficacy of the drug.

After submitting a Sacubitril And Valsartan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sacubitril And Valsartan API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Sacubitril And Valsartan suppliers with KDMF on PharmaCompass.

Sacubitril And Valsartan WC

A Sacubitril And Valsartan written confirmation (Sacubitril And Valsartan WC) is an official document issued by a regulatory agency to a Sacubitril And Valsartan manufacturer, verifying that the manufacturing facility of a Sacubitril And Valsartan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sacubitril And Valsartan APIs or Sacubitril And Valsartan finished pharmaceutical products to another nation, regulatory agencies frequently require a Sacubitril And Valsartan WC (written confirmation) as part of the regulatory process.

click here to find a list of Sacubitril And Valsartan suppliers with Written Confirmation (WC) on PharmaCompass.

Sacubitril And Valsartan NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sacubitril And Valsartan as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Sacubitril And Valsartan API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Sacubitril And Valsartan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Sacubitril And Valsartan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sacubitril And Valsartan NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Sacubitril And Valsartan suppliers with NDC on PharmaCompass.

Sacubitril And Valsartan GMP

Sacubitril And Valsartan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sacubitril And Valsartan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sacubitril And Valsartan GMP manufacturer or Sacubitril And Valsartan GMP API supplier for your needs.

Sacubitril And Valsartan CoA

A Sacubitril And Valsartan CoA (Certificate of Analysis) is a formal document that attests to Sacubitril And Valsartan's compliance with Sacubitril And Valsartan specifications and serves as a tool for batch-level quality control.

Sacubitril And Valsartan CoA mostly includes findings from lab analyses of a specific batch. For each Sacubitril And Valsartan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sacubitril And Valsartan may be tested according to a variety of international standards, such as European Pharmacopoeia (Sacubitril And Valsartan EP), Sacubitril And Valsartan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sacubitril And Valsartan USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty